MENU
MYNZ
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Mainz Biomed (MYNZ) Ownership - Who owns Mainz Biomed?
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions... Show more
Profile
Industry
N/A
Address
Robert Koch Strasse 5
Phone
+49 61315542860
Employees
64
Web
https://www.mainzbiomed.com
Details
Group
Domestic Stock Funds
Category
Medical Specialties
Capitalization
20.77M
P/E Ratio
N/A
Total Cash
9.32M
Projected Growth
N/A
Total Debt
10.16M
Revenue
874K
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.46
Total Debt/Equity
N/A
Revenue/Share
0.06 USD as % of share price
Fundamentals
MYNZ
Capitalization
20.8M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
9.32M
Total Cash/Share
0.46
Total Debt
10.2M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.06%
Revenue
874K
ROE
N/A
Book Value
3.45M
P/B Ratio
6.02
Cash Flow
N/A
Earnings
-1.92
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
188K
Current Ratio
0.97
Current Revenue Per Employee
2838.58
Dividends Per Share - Security
N/A
EBITDA
-27.15M
Float
N/A
Float - Current
N/A
Gross Income Margin
47.99
Revenue To Assets
-163.63
Shares Held By Institutions
14.8K
Shares Outstanding - Current
20.4M
Total Liabilities
14.5M
Total Volume MTD
N/A
Value
1
Gain YTD
-26.389
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry MedicalSpecialties
Profile
Fundamentals
Details
Industry
N/A
Address
Robert Koch Strasse 5
Phone
+49 61315542860
Employees
64
Web
https://www.mainzbiomed.com